Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01604668 · ClinicalTrials.gov registry record
Comparative Accuracy of Three Versions of Non-Invasive Hemoglobin Monitoring
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 10
- Enrollment target
NCT01604668: Completed study, sponsored by University of California, San Francisco.
NCT01604668 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01604668 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
There is no study hypothesis. The purpose of this study is to compare the accuracy of the: 1) SpHb (Radical 7 Pulse Co-Oximetry with SpHb™) RevF sensor (currently marketed), 2) the SpHb RevG sensor (a new, limited release version), and 3) the Pronto-7 sensor (currently marketed version) in patients undergoing spine surgery.
Primary Outcome
Comparison of hemoglobin levels derived by sensor RevF versus sensor RevG versus a hemoglobin derived from a blood sample. A baseline hemoglobin level will be taken from the Pronto-7 hand-held hemoglobin device prior to surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-05 |
What the finished NCT01604668 record still lists
NCT01604668 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01604668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01604668 about?
NCT01604668 is a clinical study titled "Comparative Accuracy of Three Versions of Non-Invasive Hemoglobin Monitoring". There is no study hypothesis. The purpose of this study is to compare the accuracy of the: 1) SpHb (Radical 7 Pulse Co-Oximetry with SpHb™) RevF sensor (currently marketed), 2) the SpHb RevG sensor (a new, limited release version), and 3) the Pronto-7 sensor (currently marketed version) in patients ...
What is the current status of trial NCT01604668?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-05. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01604668?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia